Latest total revenue for RAD: $23B, below the Healthcare sector average of $110B.
Get informed when a big investor buys or sells
+ FollowAs of Aug 2023
Trailing 12 months ending Aug 2023
As of the most recent data (August 2023), RAD shows a total revenue of $23B. That compares with $24B in the prior-year period — down 3.0% year over year. That is below the Healthcare sector average of $110B. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, RAD's total revenue is now $23B (was $24B) — a 3.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Rite Aid is outperforming or lagging.
The Healthcare sector average total revenue is about $110B. Rite Aid is at $23B, which is lower that average. That is roughly 79.5% below the sector mean. Use the comparison chart on this page to see how RAD stacks up against individual peers as well.
Tracking RAD's total revenue over time shows whether Rite Aid is scaling, shrinking, or reshaping that part of the business. The current reading is $23B That compares with $24B in the prior-year period — down 3.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this total revenue page, Stockcircle has Rite Aid's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total revenue (currently $23B) with ownership activity and broader fundamentals.